Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 125K 116K 107K 201K 13.67M 205K 1.37M 537K 6.81M 538K 527K 22.56M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.94M 18.59M 17.09M 32.23M 2.19B 32.79M 219M 85.88M 1.09B 86.18M 84.29M 3.61B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.05% | +1.02% | +23.97% | +3.66% | 212B | ||
| +1.29% | +3.13% | +0.21% | -23.41% | 137B | ||
| +6.25% | +11.23% | -22.29% | +19.61% | 125B | ||
| +3.64% | +9.45% | -54.06% | -4.33% | 69.46B | ||
| +3.20% | +7.49% | +11.96% | +10.50% | 49.56B | ||
| +6.10% | +11.55% | -15.77% | -20.80% | 47.2B | ||
| +1.03% | +0.89% | +23.17% | +9.47% | 39.08B | ||
| -0.68% | +0.02% | +29.08% | +28.44% | 37.05B | ||
| -3.38% | +2.10% | +109.34% | +4.54% | 30.97B | ||
| Average | +1.00% | +3.19% | +11.74% | +3.07% | 83.06B | |
| Weighted average by Cap. | +1.08% | +2.80% | +5.08% | +1.09% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.5M 1.4M 1.29M 2.43M 165M 2.47M 16.52M 6.47M 82.19M 6.49M 6.35M 272M | 1.98M 1.72M 1.6M 1.47M 2.78M 189M 2.83M 18.89M 7.4M 93.99M 7.43M 7.26M 311M |
| Net income | -16.08M -13.97M -13.02M -11.97M -22.58M -1.53B -22.97M -154M -60.16M -764M -60.37M -59.05M -2.53B | -29.31M -25.47M -23.75M -21.83M -41.17M -2.79B -41.88M -280M -110M -1.39B -110M -108M -4.61B |
| Net Debt | 20.53M 17.83M 16.63M 15.28M 28.83M 1.96B 29.33M 196M 76.81M 976M 77.08M 75.39M 3.23B | 22.8M 19.81M 18.47M 16.98M 32.03M 2.17B 32.58M 218M 85.34M 1.08B 85.64M 83.76M 3.59B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















